Netherlands ends OTC sale of Mylan's Inhibin

7 November 2018 - Deborah Wilkes


The Dutch Medicines Evaluation Board (MEB) has banned OTC sales of Mylan's Inhibin (hydroquinine hydrobromide) following concerns about cardiovascular safety.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: